The presence of CD36+ metastasis-initiating cells correlated with a poor prognosis for numerous carcinomas, including breast carcinoma, and the inhibition of CD36 impaired the metastasis of breast tumor cells [111]. The gene discussed is CD36; the disease is breast carcinoma.